Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

44.89
Delayed Data
As of 4:02pm ET
 -1.35 / -2.92%
Today’s Change
38.80
Today|||52-Week Range
85.83
-9.90%
Year-to-Date

Today’s Trading

Previous close46.24
Today’s open46.23
Day’s range44.85 - 46.51
Volume2,382,933
Average volume (3 months)2,104,164
Market cap$4.6B
Dividend yield--
Data as of 4:02pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+1.01%
P/E ratio24.5
Price/Sales2.30
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc-0.95-2.59%
CLVSClovis Oncology Inc-4.50-4.76%
TAROTaro Pharmaceutical ...-0.09-0.08%
AGNPRAAllergan plc-6.94-0.79%
Data as of 4:02pm ET, 06/27/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$1.73
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts